Large-scale testing (Phase 3)Study completedNCT00236444
What this trial is testing
The Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
Who this might be right for
Attention Deficit and Disruptive Behavior Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375